Cargando…
Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling
SIMPLE SUMMARY: Myelofibrosis is a disease arising from bone marrow driven by mutations in stem cells, which results in progressive failure of marrow production in red and white blood cells as well as platelets. Patients can also develop leukemia (a cancer of white blood cells) over time. While the...
Autores principales: | Reynolds, Samuel B., Pettit, Kristen, Kandarpa, Malathi, Talpaz, Moshe, Li, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527328/ https://www.ncbi.nlm.nih.gov/pubmed/37760623 http://dx.doi.org/10.3390/cancers15184654 |
Ejemplares similares
-
Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation
por: Jin, Xi, et al.
Publicado: (2022) -
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells
por: Potu, Harish, et al.
Publicado: (2019) -
The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics
por: Jarell, Abel D, et al.
Publicado: (2007) -
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis
por: Talpaz, Moshe, et al.
Publicado: (2020) -
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma
por: Potu, Harish, et al.
Publicado: (2021)